News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Gilead (GILD)'s HIV Triple Combo Gets Sped-up FDA Review, Decision Date Locked Down     8/11/2017
Merck & Co. (MRK) Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results     7/26/2017
BIO2017: BIO Urges Biotech Leaders to Get Active on Legislation     6/22/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
Inovio Pharma (INO) CEO Forging Multiple Deals, Expanding Pipeline and Adding 100 New Jobs     6/20/2017
High School Students "Punched" Martin Shkreli in the Face by Recreating $750 HIV Pill for a Mere $2     12/2/2016
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne     9/20/2016
GlaxoSmithKline (GSK) Execs Set High Hopes for Game-Changing HIV Research Strategy     8/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Theratechnologies (TH.TO) Says 82.5% of Patients Achieved Primary Endpoint in Phase III Ibalizumab Trial     5/24/2016
FDA Approves Gilead (GILD)'s Next-Generation HIV Drug Descovy     4/5/2016
FDA Green Lights Gilead (GILD)’s Odefsey to Treat HIV-1 Infection in Certain Patients     3/2/2016
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion     12/18/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015

News from Around the Web
GlaxoSmithKline (GSK) Stock Takes A Hit As Broker Cites Threat To Its HIV BIz     7/5/2017
Preventing The Spread Of HIV With One Simple Gadget     6/29/2017
Bay Area Students Tested For HIV, Hepatitis After Being Poked With Discarded Medical Device     6/8/2017
New Approach Makes Cells Resistant To HIV, The Scripps Research Institute Reveals     4/11/2017
The 3 Best HIV Drug Stocks To Buy In 2017     4/10/2017
Gazing Into The Crystal Ball For Advaxis (ADXS): What To Expect At ASCO 2017     4/7/2017
MRI Scans Can Help Spot HIV In The Brain, University College London Reveals     3/13/2017
Gilead (GILD): Buy The HIV Franchise And Get The Rest For Almost Free     2/28/2017
Cheap Ultrasensitive HIV Sensor To Help Screen Virus In Poorer Places, Instituto de Microelectrónica de Madrid Reveals     2/23/2017
Antiretroviral Therapy May Lead To Syphilis In HIV-Positive Men, Johns Hopkins University School of Medicine Study     1/20/2017
Massive Drop In London HIV Rates May Be Due To Internet Drugs, London School of Hygiene and Tropical Medicine Study     1/11/2017
The GlaxoSmithKline (GSK)-Gilead (GILD) HIV Battle Could Be Epic     12/29/2016
Needle Exchanges, Once Met With Fierce Resistance, Are Working     12/6/2016
Why Can't We Bring Down The Number Of New HIV Cases?     12/1/2016
Injections, Implants Tested As New Weapons To Prevent HIV     11/30/2016

Press Releases
Mylan (MYL) Advances Access In The Fight Against HIV With The Launch Of Three Generic Antiretroviral Medicines In Canada     8/10/2017
Mologen (MOLGF.PK): Results Of The Extension Phase Of The Exploratory Phase Ib/Iia Study In HIV     8/9/2017
CytoDyn (CYDY) Provides Update On Enrollment In Its Pivotal Phase Ib/III HIV Combination Trial     8/9/2017
Mylan (MYL) Receives Tentative Approval for "TLD" Under PEPFAR     8/7/2017
Gilead (GILD) Release: U.S. FDA Approves Expanded Labeling For Epclusa (Sofosbuvir/Velpatasvir) For The Treatment Of Chronic Hepatitis C In Patients Co-Infected With HIV     8/2/2017
INSYS Announces Availability Of SYNDROS, The First And Only FDA-Approved Liquid Dronabinol, By Prescription     7/31/2017
Effective HIV Treatment Halts HIV Transmission Among Homosexual Couples, Kirby Institute Study Finds     7/28/2017
bioLytical™ Laboratories Release: Instant HIV Home Test Launched In The Netherlands     7/28/2017
Bavarian Nordic (BAVA.CO) Rockets on Expanded $846 Million HIV-Hepatitis B Deal With Johnson & Johnson (JNJ)     7/27/2017
bioLytical™ Laboratories Release: INSTI HIV Self Test Demonstrates High User Acceptance in Kenya Study     7/27/2017
Argos (ARGS) Reports Immunogenicity Results Of AGS-004 In HIV Program     7/26/2017
Nanjing Frontier Acquires Rights To Rockefeller University HIV/AIDS Antibody     7/26/2017
Viriom Obtains First Market Approval Of Elsulfavirine (Elpida) For Treatment Of HIV-1 Infection In Russia     7/25/2017
Janssen-Cilag International NV (JNJ) Announces Phase III Pivotal Study Results for Darunavir-Based Complete Treatment Regimen     7/25/2017
Merck & Co. (MRK)'s Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint Of Non-Inferiority To Efavirenz, Both In Combination With Other Antiretroviral Agents, In Pivotal Phase III Trial For Treatment Of HIV-1 Infection     7/25/2017

//-->